.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
The Botanist is stocked at 459 licensed dispensaries across New York, Illinois, and 4 other states, 145 of them in New York, with the deepest coverage in New York, Brooklyn, Queens, Syracuse, and Rochester. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, The Botanist concentrated 65.99% of sales in Flower with a 139.59% year-over-year lift but a 0.51% month-over-month dip, while Vapor Pens held 16.18% share with a 17.10% YoY decline and a 9.54% MoM decline; Pre-Roll reached 15.77% share with an 85.32% YoY increase and a 2.33% MoM rise. Edible and Tincture & Sublingual together accounted for just 2.02% share, each down more than 47% YoY and over 13% MoM, indicating continued retrenchment in ingestibles. With Flower ranking 6th in Illinois and Vapor Pens sliding both YoY and MoM, the category mix implies a deliberate tilt toward inhalables led by Flower and Pre-Roll to capture momentum where price elasticity and velocity favor scale.
The shift toward Flower (+139.59% YoY) and Pre-Roll (+85.32% YoY) alongside Vapor Pens contraction (−17.10% YoY) and ingestibles declines (Edible −47.15% YoY; Tincture & Sublingual −48.01% YoY) suggests The Botanist is prioritizing fast-turn, basket-entry formats to defend and expand unit throughput, even as Flower’s slight 0.51% MoM dip signals near-term saturation risk. Holding a 6 rank in Illinois Flower while Edible and Tincture & Sublingual remain under 2% combined share points to a positioning anchored in core inhalables, where incremental share gains are most accessible, and where marginal pricing power (average price up 8.02% YoY) can be applied without eroding the Pre-Roll MoM growth of 2.33%.
Competitive Landscape
The Botanist sits at rank #6 in Illinois Flower in October 2026, improving 16 positions from #22 year over year and rising 2 spots from #8 in July 2026, after peaking at #4 in September 2026. Against competitors, High Supply / Supply holds #1 while declining year over year by 17.5%, and &Shine advanced from #8 to #4 with a 53.3% sales increase, indicating The Botanist’s rank gains came amid mixed top-tier momentum and a tightening spread above. The pattern—rapid ascent from #22 to #6 within a year and a recent slip from a #4 peak—implies The Botanist is consolidating into the upper tier but must defend share against faster climbers at the very top.
Notable Products
The Botanist leans on recent launches in October 2026, with 220 new products contributing 32.5% of sales and three of them appearing in the top sellers, including Purple Peachy Trainwreck (28g) and Guava Casquitos (3.5g). That depth of newness means a large share of revenue comes from products first sold in the last six months.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
